Spots Global Cancer Trial Database for Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
Official Title: Double Bypass vs Stent Strategy in Peroperatively Diagnosed Irresectable Pancreatic Cancer - A Prospective Randomized Multicenter Study
Study ID: NCT01569282
Study Description
Brief Summary: Double bypass (hepaticojejunostomy + gastrojejunostomy) is compared to stent strategy in patients planned for curative pancreatic resection in whom peroperative findings makes resection impossible.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Surgery, Sahlgrenska University Hospital, Gothenburg, , Sweden
Department of surgery, University Hospital, Linköping, , Sweden
Department of Surgery, Skane University Hospital, Lund, , Sweden
Gastro Center Surgery, Karolinska University Hospital, Stockholm, , Sweden
Department of Surgery, University Hospital, Umeå, , Sweden
Department of Surgery, University Hospital, Örebro, , Sweden
Contact Details
Name: Lars Fändriks, Professor
Affiliation: Göteborg University
Role: STUDY_CHAIR
Name: Claes Jönsson, Ass. Prof.
Affiliation: Gothenburg Universitity
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
